Product
CARv3-TEAM-E T cells
1 clinical trial
3 indications
Indication
GlioblastomaIndication
Malignant GliomaIndication
Recurrent GliomaClinical trial
INCIPIENT: INtraventricular CARv3-TEAM-E T Cells for PatIENTs With GBMStatus: Recruiting, Estimated PCD: 2025-06-01